Aims: Previous reports from our laboratory have established that morphine-6-O-sulfate (M6S) is a mixed μ/δ opioid receptor (OR) agonist and a potential improved alternative to morphine for treatment of chronic multimodal pain in non-diabetic rats. This study extends the antinociceptive effects of M6S and morphine in STZ-induced diabetic rats.
Materials And Methods: Effects of morphine and M6S were studied across a range of pain modalities, using hot plate threshold (HPT), pinprick sensitivity threshold (PST) and paw pressure threshold (PPT) tests.
Key Findings: Acutely, M6S was 3- to 5-fold more potent and 2- to 3-fold more efficacious than morphine in HPT and PST tests. No differences in analgesic drug potency/efficacy were detected in the PPT test. After 7-9days of chronic treatment, tolerance developed to the antinociceptive effects of morphine, but not to M6S, in all three pain tests. Furthermore, morphine-tolerant rats were not cross-tolerant to M6S. The selective δ-OR antagonist, naltrindole, blocked M6S-induced antinociception by 62±3% in the HPT test, 93±5% in the PST test, and 30±17% in the PPT test when examined acutely.
Significance: These studies provide additional confirmation for the mixed μ/δ activity of M6S and demonstrate potential improved clinical utility for dual μ/δ agonists relative to morphine in treatment of diabetic neuropathy across multiple pain domains.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lfs.2017.11.042 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.
Curr Oncol
January 2025
Department of Medical Oncology, Arthur JE Child Comprehensive Centre, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 5G2, Canada.
Although the majority of patients with nasopharyngeal carcinoma (NPC) present with early-stage or locoregional disease that can be treated with definitive radiotherapy, approximately 20% of patients experience disease recurrence, and 15% present with metastatic disease that is not amenable to curative therapy. Management of patients with recurrent or metastatic (r/m) NPC who are not candidates for local salvage therapy is challenging in Canada, as there is uncertainty in extrapolating evidence that is largely generated from Southeast China to non-endemic regions such as Canada. Currently, treatment options in Canada are limited to chemotherapy regimens that can only achieve short-term response and prolongation of survival.
View Article and Find Full Text PDFInto the light: A story about breast cancer radiation treatment.
J Med Imaging Radiat Sci
January 2025
686 Beresford Ave, Toronto, Ontario M6S 3C5, Canada. Electronic address:
Associations Between Added Sugars Intake from Various Food and Beverage Sources and Diet Quality Among the U.S. Population.
Nutrients
December 2024
Nutrition Impact, LLC, Battle Creek, MI 49014, USA.
A diet high in added sugars has been linked to poor diet quality; however, little is known about specific sources of added sugars and their association with diet quality. This study examined associations between added sugars intake from specific food and beverage sources and diet quality, as indicated by the Healthy Eating Index (HEI) 2020 score, among the U.S.
View Article and Find Full Text PDFEnhanced Catalytic Probe Design for Mapping Radical Density in the Plasma Afterglow.
J Phys Chem A
November 2024
Dutch Institute for Fundamental Energy Research (DIFFER), Eindhoven 5600 MB, Eindhoven, The Netherlands.
The electrification of chemical processes using plasma generates an increasing demand for sensors, monitoring concentrations of plasma-activated species such as radicals. Radical probes are a low-cost in situ method for spatially resolved quantification of the radical density in a plasma afterglow using the heat from the exothermal recombination of radicals on a catalytic surface. However, distinguishing recombination heating from other heat fluxes in the system is challenging.
View Article and Find Full Text PDFImplementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario Perspective.
Curr Oncol
October 2024
Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada.
Article Synopsis
- Lung cancer is the top cause of cancer deaths in Canada, with non-small-cell lung cancer (NSCLC) being the most common type.
- Timely molecular profiling using tissue biopsies is crucial for choosing effective targeted therapies, but challenges often lead to delays in testing and treatment.
- A multidisciplinary team in Ontario has proposed criteria for reimbursing liquid biopsies, which analyze tumor DNA in blood and could provide a quicker, less invasive alternative to tissue biopsies, aiming to improve treatment access and outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!